ScholarWorks@Gyeongsang National University

Browsing by Jung, Chul WonAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 9 of 9

SCIESCOPUS
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKoreaopen access

Shin, Junghoon; Koh, Youngil; Yoon, Seo Hyun; Cho, Joo-Youn; Kim, Dae-Young; Lee, Kyoo-Hyung; Kim, Hyeong-Joon; Ahn, Jae-Sook; Kim, Yeo-Kyeoung; Park, Jinny, et al.

ArticleIssue Date2018CitationCANCER MEDICINE, v.7, no.5, pp 1814 - 1823PublisherWILEY
SCISCIESCOPUS
Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia

Lee, Sang Min; Lee, Won Sik; Shin, Ho Jin; Lee, Je-Jung; Sohn, Sang Kyun; Moon, Joon Ho; Eom, Hyeon Seok; Won, Jong Ho; Lee, Kyoo-Hyung; Lee, Je-Hwan, et al.

ArticleIssue Date2013CitationANNALS OF HEMATOLOGY, v.92, no.8, pp 1101 - 1110PublisherSPRINGER
SCISCIESCOPUS
Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Lim, Sung-Nam; Joo, Young-Don; Lee, Kyoo-Hyung; Kim, Dae-Young; Lee, Je-Hwan; Lee, Jung-Hee; Chi, Hyun-Sook; Yun, Sung-Cheol; Lee, Won Sik; Lee, Sang Min, et al.

ArticleIssue Date2015CitationAMERICAN JOURNAL OF HEMATOLOGY, v.90, no.11, pp 1013 - 1020PublisherWILEY-BLACKWELL
SCOPUSESCIKCI
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Koreaopen access

Yi, Jun Ho; Lee, Gyeong-Won; Lee, Ji Hyun; Yoo, Kwai Han; Jung, Chul Won; Kim, Dae Sik; Lee, Jeong-Ok; Eom, Hyeon Seok; Byun, Ja Min; Koh, Youngil, et al.

ArticleIssue Date2021CitationBLOOD RESEARCH, v.56, no.4, pp 243 - 251PublisherKOREAN SOC HEMATOLOGY
SCISCIESCOPUS
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemiaopen access

Kim, Dae-Young; Joo, Young-Don; Lim, Sung-Nam; Kim, Sung-Doo; Lee, Jung-Hee; Lee, Je-Hwan; Kim, Dong Hwan (Dennis); Kim, Kihyun; Jung, Chul Won; Kim, Inho, et al.

ArticleIssue Date2015CitationBLOOD, v.126, no.6, pp 746 - 756PublisherAMER SOC HEMATOLOGY
SCOPUSESCIKCI
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Koreaopen access

Ahn, Seo-Yeon; Son, Sang Kyun; Lee, Gyu Hyung; Kim, Inho; Cheong, June-Won; Lee, Won Sik; Kim, Byung Soo; Jo, Deog-Yeon; Jung, Chul Won; Seong, Chu Myoung, et al.

ArticleIssue Date2022CitationBLOOD RESEARCH, v.57, no.2, pp 144 - 151PublisherKOREAN SOC HEMATOLOGY
SCIESCOPUS
The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients

Park, Hyunkyung; Kang, Sungbong; Kim, Inho; Kim, Sangsoo; Kim, Hyeong-Joon; Shin, Dong-Yeop; Kim, Dae-Young; Lee, Kyoo-Hyung; Ahn, Jae-Sook; Sohn, Sang-Kyun, et al.

ArticleIssue Date2022CitationLeukemia Research, v.114PublisherPergamon Press Ltd.
SCIESCOPUS
Treatment-free remission of chronic myeloid leukemia in real-world practice by the detection limit of MR4.3

Park, Sungwoo; Choi, Eun-Ji; Lee, Hyewon; Jo, Deog-Yeon; Jung, Chul Won; Kong, Jee Hyun; Kim, Hawk

ArticleIssue Date2021CitationLEUKEMIA RESEARCH, v.105PublisherPERGAMON-ELSEVIER SCIENCE LTD
SCIESCOPUS
Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients

Park, Hyunkyung; Kim, Inho; Kim, Hyeong-Joon; Shin, Dong-Yeop; Lee, Sung-Yeoun; Kwon, Oh-Hyung; Kim, Dae-Young; Lee, Kyoo-Hyung; Ahn, Jae-Sook; Park, Jinny, et al.

ArticleIssue Date2021CitationLeukemia Research, v.111PublisherPergamon Press Ltd.
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어